Prevalence of Fungal Drug Resistance in COVID-19 Infection: a Global Meta-analysis
ConclusionOur study shows the high prevalence of fungal drug resistance in COVID-19 patients and emphasizes the need to strengthen antimicrobial stewardship programs, close monitoring for treatment failure, and the emergence of resistance upon treatment.
Source: Current Fungal Infection Reports - Category: Infectious Diseases Source Type: research
More News: Aspergillus | Candida | Coronavirus | COVID-19 | Databases & Libraries | Fungal Infections | Infectious Diseases | Multidrug Resistance | Outbreaks | Science | Study